Related Experiment Videos
Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis
Y M Chen1, C T Chien, M I Hu-Tsai
1Department of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kidney International
|September 1, 1999
Summary
Pentoxifylline (PTX) treatment in rats with anti-Thy1 nephritis reduced glomerular macrophage accumulation and proliferation, and mesangial cell activation. This led to attenuated proteinuria and ameliorated glomerular sclerosis, suggesting PTX may help treat mesangial proliferative glomerulonephritis.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Glomerulonephritis is characterized by glomerular macrophage accumulation, mesangial cell proliferation, and extracellular matrix deposition.
- Pentoxifylline (PTX), a phosphodiesterase inhibitor, previously showed in vitro inhibition of rat mesangial cell proliferation and collagen production.
- This study investigated the in vivo efficacy of PTX in a rat model of mesangial proliferative nephritis (anti-Thy1 disease).
Purpose of the Study:
- To evaluate the therapeutic effects of pentoxifylline (PTX) on established anti-Thy1 nephritis in rats.
- To assess PTX's impact on key pathological features including glomerular macrophages, mesangial cells, and extracellular matrix.
- To determine if PTX can reduce proteinuria and glomerular sclerosis in this nephritis model.
Main Methods:
- Anti-Thy1 nephritis was induced in rats, followed by random assignment to PTX or vehicle treatment.
- Kidney tissues were analyzed for histology, cellularity, sclerosis, and expression of markers for proliferation (PCNA), macrophages (ED-1), and activated cells (alpha-SMA).
- Glomerular mRNA levels of MCP-1, ICAM-1, collagens, and fibronectin were quantified, alongside urinary protein excretion.
Main Results:
- PTX treatment significantly reduced urinary protein excretion and attenuated glomerular cellularity and sclerosis.
- PTX decreased glomerular mRNA levels of MCP-1 and ICAM-1, and reduced the accumulation/proliferation of glomerular macrophages.
- PTX suppressed mesangial cell activation/proliferation and attenuated the expression of type I, III, and IV collagen and fibronectin on day 5 of nephritis.
Conclusions:
- Pentoxifylline (PTX) administration ameliorates key pathological features of anti-Thy1 glomerulonephritis in rats.
- PTX effectively reduces glomerular macrophage and mesangial cell proliferation and extracellular matrix deposition.
- These findings suggest PTX holds potential for managing acute phases or relapses of mesangial proliferative glomerulonephritis.